Bipolar Disorder
Bipolar Disorder is a mood disorder characterized by recurring episodes of mania or hypomania alternating with depressive episodes. The DSM-5-TR distinguishes Bipolar I (full manic episodes), Bipolar II (hypomanic + major depressive episodes), and Cyclothymic Disorder.
Overview
Bipolar Disorder is a chronic, episodic mood disorder defined by the occurrence of mania or hypomania alongside depressive episodes. The DSM-5-TR includes three principal diagnoses in the bipolar and related disorders class: Bipolar I Disorder (296.4x-296.7), defined by at least one full manic episode; Bipolar II Disorder (296.89), defined by at least one hypomanic episode and at least one major depressive episode without a history of full mania; and Cyclothymic Disorder (301.13), defined by 2+ years (1+ year in youth) of subthreshold hypomanic and depressive symptoms.
Lifetime prevalence is approximately 1% for Bipolar I and 1.1% for Bipolar II in U.S. and Canadian samples; combined bipolar-spectrum prevalence is approximately 4-5% when subthreshold presentations are included. Onset is typically in late adolescence or early adulthood (median age 18-22 for Bipolar I, slightly later for Bipolar II), with childhood and late-adult-onset cases representing important diagnostic considerations.
Bipolar Disorder is associated with substantial morbidity and mortality. Functional impairment between episodes is common; many individuals do not return to baseline cognitive or occupational functioning between episodes. Suicide risk is among the highest of any psychiatric diagnosis — approximately 15-20 times that of the general population — with lifetime suicide-attempt rates of 30-50% and completion rates around 5-15%. Comorbid substance use disorders, anxiety disorders, ADHD, and metabolic syndrome are common.
The diagnostic delay between symptom onset and accurate diagnosis is substantial — averaging 5-10 years across studies. The most common diagnostic error is identifying bipolar depression as unipolar major depressive disorder, leading to antidepressant monotherapy that may precipitate switches to mania, mixed episodes, or rapid cycling. Careful history-taking for past hypomanic or manic episodes is essential in any patient presenting with depression.
Effective treatment is available and substantially improves both acute episodes and long-term outcome. Combined pharmacotherapy and psychosocial intervention — particularly psychoeducation, cognitive behavioral therapy, and family-focused therapy — produces meaningful improvements in mood stability, functional outcomes, and quality of life.
Signs and symptoms
- Mania: elevated, expansive, or irritable mood — Distinct period of abnormally and persistently elevated, expansive, or irritable mood and increased goal-directed activity, lasting at least one week (or any duration if hospitalization is necessary).
- Mania: inflated self-esteem or grandiosity — Markedly increased self-importance, special abilities, or grandiose plans during the manic episode.
- Mania: decreased need for sleep — Feeling rested after only a few hours of sleep — distinct from insomnia, which involves wanting but being unable to sleep.
- Mania: pressured speech or racing thoughts — More talkative than usual; pressure to keep talking; subjective experience of accelerated thinking.
- Mania: distractibility — Attention easily drawn to unimportant external stimuli during the episode.
- Mania: increased goal-directed activity or psychomotor agitation — Marked increase in activity socially, at work or school, sexually, or in pursuing projects.
- Mania: excessive involvement in pleasurable activities with high consequence potential — Spending sprees, sexual indiscretions, foolish business investments, or other risky activity.
- Hypomania — Same symptom profile as mania but milder, lasting at least 4 consecutive days, not severe enough to cause marked impairment, hospitalization, or psychotic features.
- Major depressive episode — Persistently depressed mood or loss of interest, sleep and appetite changes, fatigue, worthlessness or guilt, concentration difficulties, suicidal ideation — for at least 2 weeks.
- Mixed features — Symptoms of opposite polarity present concurrently — e.g., depressed mood with racing thoughts and pressured speech; substantially elevates suicide risk.
Diagnostic context
The DSM-5-TR criteria for the bipolar disorders are summarized below:
Bipolar I Disorder (296.4x-296.7): at least one manic episode (Criterion A: distinct period of abnormally and persistently elevated, expansive, or irritable mood and increased goal-directed activity, lasting at least 1 week or any duration if hospitalization required). The manic episode must include at least 3 (4 if mood is only irritable) of: inflated self-esteem or grandiosity, decreased need for sleep, more talkative than usual, flight of ideas or racing thoughts, distractibility, increased goal-directed activity or psychomotor agitation, excessive involvement in activities with high potential for painful consequences. The disturbance causes marked impairment, requires hospitalization, or includes psychotic features. Major depressive and hypomanic episodes are common but not required.
Bipolar II Disorder (296.89): at least one hypomanic episode (4 days minimum, similar symptom profile to mania but not causing marked impairment, hospitalization, or psychosis) and at least one major depressive episode. There has never been a manic episode.
Cyclothymic Disorder (301.13): for at least 2 years (1 year in children and adolescents), numerous periods with hypomanic symptoms and depressive symptoms that do not meet full criteria for hypomanic episode or major depressive episode, present at least half the time, with no symptom-free interval longer than 2 months.
Specifiers include: with anxious distress, with mixed features, with rapid cycling (4+ mood episodes in 12 months), with melancholic features, with atypical features, with mood-congruent or mood-incongruent psychotic features, with catatonia, with peripartum onset, with seasonal pattern.
Differential diagnosis includes major depressive disorder (always assess for past hypomania/mania), schizoaffective disorder, ADHD (where hyperactivity and distractibility may resemble hypomania), substance/medication-induced mood disorder, mood disorder due to another medical condition, borderline personality disorder, and cyclothymic disorder. The Mood Disorder Questionnaire (MDQ), Hypomania Checklist (HCL-32), and structured clinical interview are widely used assessment instruments.
Causes and risk factors
Bipolar Disorder is a highly heritable mood disorder with complex genetic and environmental contributions:
Genetic factors: heritability is approximately 60-85%, among the highest of any psychiatric disorder. First-degree relatives of individuals with bipolar I have approximately 5-10x increased risk. Multiple common variants of small effect contribute, with overlap to schizophrenia, major depressive disorder, and ADHD genetic architecture.
Neurobiological factors: bipolar disorder is associated with abnormalities in monoaminergic neurotransmission, neuroplasticity (BDNF, glutamatergic signaling), circadian rhythm regulation, and HPA-axis function. Structural and functional neuroimaging show alterations in prefrontal-limbic circuits.
Trigger factors: sleep deprivation, jet lag and time-zone changes, postpartum period, antidepressant use without mood stabilizer, substance use (especially stimulants and cannabis), and major life stressors can precipitate episodes in vulnerable individuals.
Developmental factors: childhood adversity, particularly emotional abuse and neglect, is associated with earlier onset and more severe course. Family environment characterized by high expressed emotion is associated with poorer outcomes.
Comorbidity: anxiety disorders (40-90%), substance use disorders (40-60%), ADHD (10-20%), eating disorders, personality disorders, and metabolic syndrome are commonly comorbid. Comorbidity affects treatment selection and prognosis.
Cycle acceleration: longer untreated illness, frequent episodes, and certain medication patterns (antidepressant monotherapy) can contribute to cycle acceleration and treatment resistance over time. Early effective treatment is associated with better long-term course.
Typical treatments
Treatment is delivered across acute (mania, depression, mixed) and maintenance phases, with specific evidence-based pharmacotherapy and psychosocial components:
Mood stabilizers: lithium remains the foundational mood stabilizer with the strongest evidence for both manic and depressive phases and unique anti-suicide effects. Valproate, carbamazepine, and lamotrigine are also widely used. Lamotrigine is particularly useful for bipolar depression and maintenance.
Atypical antipsychotics: quetiapine, olanzapine, risperidone, aripiprazole, lurasidone, cariprazine, and others have FDA/Health Canada approvals for various phases. Quetiapine and lurasidone have particular evidence for bipolar depression. Olanzapine + fluoxetine combination is approved for bipolar depression.
Antidepressants in bipolar disorder: use is controversial. Antidepressant monotherapy is generally avoided due to risk of switch to mania or rapid cycling. When antidepressants are used for bipolar depression, they are combined with a mood stabilizer or atypical antipsychotic; SSRIs (sertraline) and bupropion have lower switch risk than SNRIs and tricyclics.
Psychoeducation: structured psychoeducation programs (group or individual) substantially reduce relapse rates and improve treatment adherence. Patient and family psychoeducation are evidence-based first-line interventions.
Cognitive Behavioral Therapy for bipolar disorder — modified CBT addressing prodromal symptom recognition, behavioral activation in depression, sleep regulation, and cognitive restructuring — has substantial evidence as an adjunct to pharmacotherapy.
Interpersonal and Social Rhythm Therapy (IPSRT): developed specifically for bipolar disorder, IPSRT targets the circadian-rhythm dimension of episodes through structured daily routines, sleep regulation, and interpersonal problem-solving. Strong evidence base.
Family-Focused Therapy: structured family intervention with substantial evidence for reducing relapse in adolescents and adults with bipolar disorder.
Neurostimulation: ECT is highly effective for severe depression, mania, and mixed states; it is the most effective acute treatment for bipolar depression. rTMS has emerging evidence for bipolar depression.
Lifestyle interventions: regular sleep-wake schedule, alcohol and substance avoidance, stress management, regular exercise, and avoidance of significant time-zone changes when possible.
When to seek help
Professional evaluation is indicated when:
- You have experienced periods of unusually elevated, expansive, or irritable mood with decreased need for sleep, racing thoughts, or impulsive behavior — particularly if these are followed by depressive episodes.
- You have been treated for depression with antidepressants without lasting improvement, or with worsening over time.
- A first-degree family member has bipolar disorder and you are experiencing mood symptoms.
- You are in the postpartum period and experiencing severe mood elevation or rapid mood swings.
- You experience cycles of high productivity and creativity followed by significant collapses.
- You are experiencing suicidal thoughts, particularly during depressive or mixed episodes.
Bipolar Disorder carries one of the highest suicide rates of any psychiatric diagnosis — particularly during depressive and mixed episodes. If you are experiencing suicidal thoughts, free 24-hour support is available across Canada at 9-8-8 (Suicide Crisis Helpline, call or text), 1-833-456-4566 (Talk Suicide Canada), or 811 (Health Link). Acute manic episodes may require emergency evaluation and possible hospitalization to ensure safety.
Frequently asked questions
How is bipolar disorder different from depression?
Is bipolar disorder lifelong?
Do antidepressants cause bipolar disorder?
What is rapid cycling?
Can I drink alcohol or use cannabis with bipolar disorder?
Will I need medication forever?
References
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.). APA.
- Yatham, L. N., et al. (2018). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders, 20(2), 97–170.
- Goodwin, F. K., & Jamison, K. R. (2007). Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression (2nd ed.). Oxford University Press.
- Frank, E. (2005). Treating Bipolar Disorder: A Clinician's Guide to Interpersonal and Social Rhythm Therapy. Guilford Press.
- Miklowitz, D. J., et al. (2007). Family-focused treatment for adolescents with bipolar disorder. Archives of General Psychiatry, 64(9), 1053–1061.
Find the pattern behind what's been feeling hard
A few simple questions to help surface the concerns that may fit best.
Find Your PatternFind a Therapist by City
Browse therapy availability by city to see local and virtual options, explore services, and connect with a clinician who can serve your area.
Find a Therapist by Province
Browse therapy options by province to see which clinicians are available to work with clients in your region.
Trusted by Leading Psychology & Mental Health Organizations Across Canada
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Trusted By Alberta’s Leading Psychology & Mental Health Organizations
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.
Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.
